Hexcel vs. Rocket Lab USA: Which Aerospace Stock Is a Better Buy in 2026?

The article contrasts Hexcel (FY2025 revenue ~ $1.9B, net income ~ $109.4M, FCF ~ $307.2M) with Rocket Lab (FY2025 revenue ~ $601.8M, +38% YoY, net loss ~ $198.2M, FCF ~ -$321.8M), arguing Rocket Lab offers higher growth as it moves toward vertically integrated space infrastructure. Rocket Lab’s planned ~ $8B acquisition of Iridium Communications is positioned as a key growth catalyst, but it raises integration/leverage risk given ongoing unprofitability. Valuation is characterized as Hexcel trading at ~43.2x forward P/E (Rocket Lab N/A due to losses), leading to the article’s recommendation to favor Rocket Lab for 2026 despite higher volatility.

Analysis

Hexcel is the lower-volatility way to express an aerospace recovery: its earnings are mostly a function of OEM rate discipline, so the stock should respond more to Boeing/Airbus cadence than to any idiosyncratic company execution. That means the upside is real but mechanically capped — if narrow-body production normalizes, you get operating leverage, but not a structural multiple re-rating unless management proves it can sustain free cash flow through another downcycle. The main loser in that setup is any adjacent supplier with weaker balance sheets and less pricing power; HXL’s stickier content and cash generation should let it outcompete weaker composite names on share of wallet.

Rocket Lab is a different animal: the market is paying for platform optionality, not current earnings, so the stock is hostage to milestone execution, financing optics, and launch-risk headlines over the next 1-3 quarters. The second-order issue is that a successful move into bundled space infrastructure could pressure satellite-data and small-launch peers like PL and BKSY, but that competitive threat is years away unless RKLB proves it can monetize integration faster than expected. Near term, any stumble on Neutron, integration complexity, or deal financing would hit the equity harder than the headline growth rate implies because the valuation leaves little room for dilution or schedule slip.

The contrarian read is that consensus may be underpricing HXL’s quality and overpricing RKLB’s narrative durability. In a risk-off tape, free-cash-flow producers with real customer lock-in tend to outperform high-duration stories that still need external capital, especially if government funding or launch cadence softens. What would falsify the thesis: a clean sequence of Neutron and backlog wins with no dilution for RKLB, or a renewed Boeing/Airbus production disruption that pushes HXL revenue back into contraction.

Key Decisions for Investors

• Prefer long HXL over long RKLB on a 6-12 month horizon; use HXL as the cash-flowing aerospace exposure while waiting for clearer evidence that RKLB can convert growth into sustainable free cash flow.
• Pair trade: long HXL / short RKLB into strength in the next 2-6 weeks, with the short leg sized smaller because RKLB has higher upside convexity if execution milestones land; cover if RKLB secures financing/contract wins without dilution.
• If you want to own the space theme, use call spreads on RKLB rather than outright equity to limit financing/dilution risk; treat any missed launch or slipped Neutron milestone as a stop-loss signal.
• Watch BA production updates and HXL order commentary as the key catalyst for HXL; if OEM rates re-accelerate for two consecutive quarters, add on pullbacks, but exit if customer concentration translates into renewed inventory destocking.
• Avoid chasing IRDM until the acquisition/integration path is clearer; if deal spreads widen or funding conditions tighten, that is a signal to reduce any incidental exposure to the broader satellite-services complex.